Therapyx
About:
TherapyX is a privately held development-stage biotechnology company.
Website: http://therapyxinc.com/
Top Investors: National Institute of Allergy and Infectious Diseases
Description:
TherapyX is a privately held development-stage biotechnology company committed to innovating their industry and changing the future of pharmaceuticals by engaging in the discovery and development of microparticulate immune therapeutics to treat infectious disease, immune-mediated inflammatory disorders and cancer.
Total Funding Amount:
$2.8M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Buffalo, New York, United States
Founded Date:
Contact Email:
dauci(AT)therapyxinc.com
Founders:
Nejat K. Egilmez
Number of Employees:
11-50
Last Funding Date:
2020-08-11
IPO Status:
Private
Industries:
© 2025 bioDAO.ai